Search

Your search keyword '"TUBERCULOSIS patients"' showing total 8,618 results

Search Constraints

Start Over You searched for: Descriptor "TUBERCULOSIS patients" Remove constraint Descriptor: "TUBERCULOSIS patients"
8,618 results on '"TUBERCULOSIS patients"'

Search Results

1. Silicosis predicts drug resistance and retreatment among tuberculosis patients in India: a secondary data analysis from Khambhat, Gujarat (2006–2022).

2. Construction and evaluation of a risk prediction model for linezolid-related neurological adverse reactions in patients with multidrug-resistant tuberculosis.

3. Nanopore-targeted sequencing (NTS) for intracranial tuberculosis: a promising and reliable approach.

4. Differential Diagnosis of Tuberculosis and Sarcoidosis by Immunological Features Using Machine Learning.

5. Impact of the COVID-19 pandemic and migration on tuberculosis notifications: a retrospective analysis with 5-year data from three centers.

6. Histopathological Spectrum of Cardiac Tuberculosis on Autopsy: Series of 11 Cases.

7. Estimation of potential social support requirement for tuberculosis patients in India.

8. Multifocal Choroiditis, Nodular Episcleritis and Myelitis in an Immunocompetent Patient with Disseminated Tuberculosis: A Case Report.

9. Further analysis of tuberculosis in eight high-burden countries based on the Global Burden of Disease Study 2021 data.

10. Epidemiological characteristics, diagnosis and treatment effect of rifampicin-resistant pulmonary tuberculosis (RR-PTB) in Guizhou Province.

11. Impact of pyrazinamide usage on serious adverse events in elderly tuberculosis patients: A multicenter cohort study.

12. Deciphering the possible role of MmpL7 efflux pump in SQ109 resistance in Mycobacterium tuberculosis.

13. Evaluation of molecular and bacteriological detection methods performed on the formalin-fixed paraffin-embedded biopsy samples collected from endometrial and lymph node tuberculosis suspected patients.

14. Status and influencing factors of treatment delay of rifampicin resistant tuberculosis patients, Guizhou, 2016-2022.

15. Single molecule measurements of microRNAs in the serum of patients with pulmonary tuberculosis.

16. Medication-related burden and its association with medication adherence among elderly tuberculosis patients in Guizhou, China: a cross-sectional study.

17. Dynamic changes of respiratory microbiota associated with treatment outcome in drug-sensitive and drug-resistant pulmonary tuberculosis.

18. Exploring expression levels of the cGAS-STING pathway genes in peripheral blood mononuclear cells of spinal tuberculosis patients.

19. Clinical profiles and related factors in tuberculosis patients with positive sputum smear mycobacterium tuberculosis tests.

20. Performance of metagenomic Next-Generation Sequencing and metagenomic Nanopore Sequencing for the diagnosis of tuberculosis in HIV-positive patients.

21. E-counseling development model: modified Psycho-Spiritual and Spiritual Emotional Freedom Technique (PS-SEFT) on anxiety levels and recovery motivation in pulmonary Tuberculosis patients.

22. 基于潜变量增长模型的初治结核病患者失眠症状纵向轨迹分析.

23. Association of SARS-CoV-2 Seropositivity with Persistent Immune Activation in HIV/Tuberculosis Co-Infected Patients.

24. A Comparative Study on Assessment of Burden and Quality of Life Among Caregivers of Bipolar Disorder and Tuberculosis Patients.

25. Spatiotemporal analysis of regional and age differences in tuberculosis prevalence in mainland China.

26. Prediabetes and the treatment outcome of tuberculosis: A meta‐analysis.

27. Tuberculosis infection among close contacts of patients with pulmonary tuberculosis in China: a population-based, multicentered study.

28. META-TAXONOMIC PROFILING OF MICROBIAL COOCCURRENCE PATTERNS IN THE LUNGS OF TUBERCULOSIS PATIENTS.

29. Health worker perspectives on barriers and facilitators of tuberculosis investigation coverage among index case contacts in rural Southwestern Uganda: a qualitative study.

30. Factors affecting the readiness for hospital discharge of initially treated pulmonary tuberculosis patients in China: a phenomenological study.

31. An approach to integrated management of diabetes in tuberculosis patients: Availability and readiness of the health facilities of Bangladesh.

32. Non-communicable comorbidities in pulmonary tuberculosis and healthcare utilization: a cross-sectional study of 2021 Indonesian national health insurance data.

33. Predictors of mortality among multidrug-resistant tuberculosis patients after decentralization of services in Tanzania from 2017 to 2019: retrospective cohort study.

34. Drug resistance in drug-resistant tuberculosis patients with and without diabetes mellitus: a comparative analysis.

35. Impact of serum chitotriosidase activity on tuberculosis treatment response: single center study from Serbia.

36. Clinical risk factors for moderate and severe antituberculosis drug-induced liver injury.

37. 2019-2021 年徐州市肺结核流行病学特征 及影响因素的 Logistic 回归预测模型建立.

38. 2017--2021年青海省结核分枝杆菌耐药现状 及其特征分析.

39. The role of chest X-rays when screening for latent tuberculosis infection in patients with inflammatory bowel disease before starting biologic treatment.

40. The Association of Chronic Pulmonary Aspergillosis and Chronic Pulmonary Histoplasmosis with MDR-TB Patients in Indonesia.

41. Effect of Interindividual Variability in Metabolic Clearance and Relative Bioavailability on Rifampicin Exposure in Tuberculosis Patients with and without HIV Co-Infection: Does Formulation Quality Matter?

42. Diagnostic evaluation of Tru-Nat MTB/Rif test in comparison with microscopy for diagnosis of pulmonary tuberculosis at tertiary care hospital of eastern Uttar Pradesh.

43. Approaching a patient with poststernal pain after eating: A case report.

44. (Re-)introduction of TNF antagonists and JAK inhibitors in patients with previous tuberculosis: a systematic review.

45. Mycotic Pseudoaneurysm of the Internal Mammary Artery: An Unusual Complication of Tuberculosis—Managed with Percutaneous Glue Embolization.

46. Initial Misdiagnosis of Lung Cancer due to Elevated Carcinoembryonic Antigen in a Patient with Tuberculosis.

47. The levels of soluble CD137 are increased in tuberculosis patients and associated with disease severity and prognosis.

48. Perceived access to social support during and after TB treatment in Mbeya and Songwe regions, Tanzania: perspectives from TB patients and survivors set against health care providers.

49. Admission vital signs in hospitalised Covid-19 patients with tuberculosis co-infection.

50. Peripheral blood MR1 tetramer‐positive mucosal‐associated invariant T‐cell function is modulated by mammalian target of rapamycin complex 1 in patients with active tuberculosis.

Catalog

Books, media, physical & digital resources